surmount-1 tirzepatide non-diabetic weight loss SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, SURPASS to SURMOUNT: The Tirzepatide
Description
Weight loss through lifestyle modification significantly reduces features of NASH
Will I lose more weight if I take both medications
In the UK/US, private clinics often offer it for menopause weight gaineven without diabetes
*These statements have not been evaluated by the Food and Drug Administration
Many patients experience significant weight loss when treatment is combined with healthy lifestyle changes
